FDA Approves New Drug for This Chronic Inflammatory Liver Disease

Source link :

The FDA has granted accelerated approval to a novel drug for the treatment of a rare autoimmune disease that damages the liver. Primary biliary cholangitis (PBC) occurs when the immune system attacks the bile ducts, leading to liver damage and other serious health outcomes. Treatment options for PBC are limited and frequently not well-tolerated by […]

Author : News Health

Publish date : 2024-06-24 23:35:20

Copyright for syndicated content belongs to the linked Source.